Summary
Mechanistic possibilities responsible for nonlinear shapes of the dose-response relationship in chemical carcinogenesis are discussed. (i) Induction and saturation of enzymatic activation and detoxification processes and of DNA repair affect the relationship between dose and steady-state DNA adduct level; (ii) The fixation of DNA adducts in the form of mutations is accelerated by stimulation of the cell division, for instance due to regenerative hyperplasia at cytotoxic dose levels; (iii) The rate of tumor formation results from a superposition of the rates of the individual steps. It can become exponential with dose if more than one step is accelerated by the DNA damage exerted by the genotoxic carcinogen. The strongly sigmoidal shapes often observed for dose-tumor incidence relationships in animal bioassays supports this analysis. A power of four for the dose in the sublinear part of the curve is the maximum observed (formaldehyde). In contrast to animal experiments, epidemiological data in humans rarely show a significant deviation from linearity. The discrepancy might be explained by the fact that a large number of genes contribute to the overall sensitivity of an individual and to the respective heterogeneity within the human population. Mechanistic nonlinearities are flattened out in the presence of genetic and life-style factors which affect the sensitivity for the development of cancer. For a risk assessment, linear extrapolation from the high-dose incidence to the spontaneous rate can therefore be appropriate in a heterogeneous population even if the mechanism of action would result in a nonlinear shape of the dose-response curve in a homogeneous population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Armitage, P. (1985). Multistage models of carcinogenesis. Environ. Health Perspect. 63, 195–201.
Belinsky, S.A., White, C.M., Devereux, T.R., Swenberg, J.A., Anderson, M.W. (1987). Cell selective alkylation of DNA in rat lung following low dose exposure to the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridy1)-1- butanone. Cancer Res. 47, 1143–1148.
Buss, P., Lutz, W.K, (1988). Steady-state DNA adduct level in rat liver after chronic exposure to low doses of aflatoxin B1 and 2-acetylaminofluorene. Proc. Amer. Assoc. Cancer Res. 29, 96.
Harris, C.C. (1989). Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair. Carcinogenesis 10, 1563–1566.
Heck, H.A., Casanova, M. (1987). Isotope effects and their implfcations for the covalent binding of inhaled (3H) and (14C) formaldehyde in the rat nasal mucosa. Toxicol. Appl. Pharmacol. 89, 122–134.
Hoel, D.G., Haseman, J.K., Hogan, M.D., Huff, J., McConnell, E.E. (1988). The impact of toxicity on carcinogenicity studies: implications for risk assessment. Carcinogenesis 9, 2045–2052.
Kaisary, A., Smith, P., Jaczq, E., McAllister, C.B., Wilkinson, G.R., Ray, W.A., Branch, R.A. (1987). Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors. Cancer Res. 47, 5488–5493.
Lutz, W.K. (1987). Quantitative Evaluation of DNA-Binding Data In Vivo for Low-Dose Extrapolations. Arch. Toxicol. (Suppl) 11, 66–74.
Lutz, W.K. (1990). Endogenous genotoxic agents and processes as a basis of spontaneous carcinogenesis. Mutat. Res., in press.
Neumann, H.G. (1980). Dose-response relationship in the primary lesion of strong electrophilic carcinogens. Arch. Toxicol. (Suppl) 3, 69–77.
Peto, R., Gray, R., Brantom, P., Grasso, P. (1984). Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting and of species. IARC Sci. Publ. 57, 627–665.
Swenberg, J.A., Barrow, C.S., Boreiko, C.J., Heck, H.A., Levine, R.J., Morgan, K.T., Starr, T.B. (1983). Non-linear biological responses to formaldehyde and their implications for carcinogenic risk assessment. Carcinogenesis 4, 945–952.
Swenberg, J.A., Richardson, F.C., Boucheron, J.A., Deal, F.H., Belinsky, S.A., Charbonneau, M., Short, B.G. (1987). High to low dose extrapolation: critical determinants involved in the dose response of carcinogenic substances. Environ. Health Perspect. 76, 57–63.
Zeise, L., Wilson, R., Crouch, E.A.C. (1987). Dose-response relationships for carcinogens: a review. Environ. Health Perspect. 73, 259–308.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Lutz, W.K. (1991). Dose-Response Relationships in Chemical Carcinogenesis: From DNA Adducts to Tumor Incidence. In: Witmer, C.M., Snyder, R.R., Jollow, D.J., Kalf, G.F., Kocsis, J.J., Sipes, I.G. (eds) Biological Reactive Intermediates IV. Advances in Experimental Medicine and Biology, vol 283. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5877-0_16
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5877-0_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5879-4
Online ISBN: 978-1-4684-5877-0
eBook Packages: Springer Book Archive